Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with ad-vanced melanoma treated with nivolumab
Academic Article
Publication Date:
2018
Short description:
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with ad-vanced melanoma treated with nivolumab / Capone, M., Giannarelli, D., Mallardo, D., Madonna, G., Festino, L., Grimaldi, A.m., Vanella, V., Si-meone, E., Paone, M., Palmieri, G., Cavalcanti, E., Caracò, C., Ascierto, P.a.. - In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. - ISSN 2051-1426. - 16:(2018). [10.1186/s40425-018-0383-1]
Iris type:
1.1 Articolo in rivista
List of contributors:
Capone, M; Giannarelli, D; Mallardo, D; Madonna, G; Festino, L; Grimaldi, Am; Vanella, V; Si-meone, E; Paone, M; Palmieri, G; Cavalcanti, E; Caracò, C; Ascierto, Pa
Published in: